AAAAAA
Results:
1-20
|
Results: 20
Authors:
COHENHAGUENAUER O
RESTREPO LM
MASSET M
BAYER J
DALCORTIVO L
MAROLLEAU JP
BENBUNAN M
BOIRON M
MARTY M
Citation: O. Cohenhaguenauer et al., EFFICIENT TRANSDUCTION OF HEMATOPOIETIC CD34(-ORIGIN USING AN ORIGINAL RETROVIRAL VECTOR DERIVED FROM F-MULV-FB29 - IN-VITRO ASSESSMENT() PROGENITORS OF HUMAN), Human gene therapy, 9(2), 1998, pp. 207-216
Authors:
COHENHAGUENAUER O
DAMS H
MASSET M
DUMEY N
DEVAUCHELLE P
CUSSENOT O
COTARD JP
LEDUC A
MARTY M
Citation: O. Cohenhaguenauer et al., IN-VIVO RETROVIRAL-MEDIATED GENE-TRANSFER INTO BLADDER RESULTS INTO PREFERENTIAL TRANSDUCTION OF TUMORS CELLS, Annals of oncology, 9, 1998, pp. 583-583
Authors:
COHENHAGUENAUER O
SEROVASINILNIKOVA O
BIGNON YJ
CARTEAU AE
LENOIR G
MARTY M
Citation: O. Cohenhaguenauer et al., BRCA1-MUTATIONS IN 2 PEDIGREES WITH BREAST-CANCER AND MELANOMA, Annals of oncology, 9, 1998, pp. 585-585
Authors:
COHENHAGUENAUER O
Citation: O. Cohenhaguenauer, EUREGENETHY REGULATION OF GENE-THERAPY - A EUROPEAN NETWORK OF USERS - DGXII E.5 BIOMED II ELSA-CA, Annals of oncology, 9, 1998, pp. 646-646
Authors:
COHENHAGUENAUER O
MASSET M
SETTERBLAD N
LOTENFOEL J
JOENJE H
GLUCKMAN E
MATHEW C
BOIRON M
MARTY M
Citation: O. Cohenhaguenauer et al., DESIGN OF A NOVEL RETROVIRUS VECTOR DERIVED FROM FR-MULV FB29 AND APPLICATION TO THE TRANSFER OF FANCONI-ANEMIA-A GENE, British Journal of Haematology, 102(1), 1998, pp. 80-80
Authors:
COHENHAGUENAUER O
RESTREPO LM
BAYER J
MASSET M
NEVO N
DALCORTIVO L
MAROLLEAU JP
MARTY M
Citation: O. Cohenhaguenauer et al., DESIGN AND EVALUATION OF A NOVEL FRIEND-VIRUS RETROVIRAL VECTOR FOR GENE-THERAPY, European journal of cancer, 33, 1997, pp. 113-113
Authors:
COHENHAGUENAUER O
Citation: O. Cohenhaguenauer, GENE-THERAPY - REGULATORY ISSUES AND INTERNATIONAL APPROACHES TO REGULATION, Current opinion in biotechnology, 8(3), 1997, pp. 361-369
Authors:
COHENHAGUENAUER O
Citation: O. Cohenhaguenauer, AGAIN MORE DIRECTIVES, Biofutur, (163), 1997, pp. 21-23
Authors:
COHENHAGUENAUER O
RESTREPO LM
MASSET M
BAYER J
PELLERAIN N
DALCORTIVO L
MAROLLEAU JP
BENBUNAN M
BOIRON M
MARTY M
Citation: O. Cohenhaguenauer et al., TRANSDUCTION OF HUMAN CD34-MULV AND CLINICALLY RELEVANT PROCEDURES( HEMATOPOIETIC PROGENITORS OF VARIOUS ORIGIN USING AN ORIGINAL RETROVIRUS VECTOR DERIVED FROM FR), HEM CELL TH, 38(2), 1996, pp. 205-206
Authors:
COHENHAGUENAUER O
Citation: O. Cohenhaguenauer, GENE-THERAPY IN EUROPE, Transfusion science, 17(1), 1996, pp. 185-190
Authors:
COHENHAGUENAUER O
Citation: O. Cohenhaguenauer, THE RIGHT TECHNOLOGY FOR THE RIGHT PATHOL OGY, Biofutur, (162), 1996, pp. 11-17
Authors:
COHENHAGUENAUER O
Citation: O. Cohenhaguenauer, OVERVIEW OF REGULATION OF GENE-THERAPY IN EUROPE - A CURRENT STATEMENT INCLUDING REFERENCE TO US REGULATION, Human gene therapy, 6(6), 1995, pp. 773-785
Authors:
BLAESE M
BLANKENSTEIN T
BRENNER M
COHENHAGUENAUER O
GANSBACHER B
SORRENTINO B
VELU T
Citation: M. Blaese et al., EUROPEAN SCHOOL OF ONCOLOGY POSITION PAPER - GENE-THERAPY FOR THE MEDICAL ONCOLOGIST, European journal of cancer, 31A(9), 1995, pp. 1531-1537
Authors:
COHENHAGUENAUER O
RESTREPO LM
UPEGUIGONZALEZ LC
MASSEL M
BOIRON M
MARTY M
Citation: O. Cohenhaguenauer et al., TRANSFER OF THE METALLOTHIONEIN GENE TO CD34(-VIRUS DERIVED CONSTRUCTCONFERS RESISTANCE TO CIS-PLANTINIUM DERIVATIVES AND TO ALKYLATING-AGENTS() CELLS USING AN ORIGINAL FRIEND), European journal of cancer, 31A, 1995, pp. 32-32
Authors:
BLAESE M
BLANKENSTEIN T
BRENNER M
COHENHAGUENAUER O
GANSBACHER B
RUSSELL S
SORRENTINO B
VELU T
Citation: M. Blaese et al., VECTORS IN CANCER-THERAPY - HOW WILL THEY DELIVER, Cancer gene therapy, 2(4), 1995, pp. 291-297
Authors:
NAROD SA
FORD D
DEVILEE P
BARKARDOTTIR RB
LYNCH HT
SMITH SA
PONDER BAJ
WEBER BL
GARBER JE
BIRCH JM
CORNELIS RS
KELSELL DP
SPURR NK
SMYTH E
HAITES N
SOBOL H
BIGNON YJ
CHANGCLAUDE J
HAMANN U
LINDBLOM A
BORG A
PIVER MS
GALLION HH
STRUEWING JP
WHITTEMORE A
TONIN P
GOLDGAR DE
EASTON DF
MILNER B
ALLAN L
SIMARD J
ROMMENS J
MCGILLIVRAY B
GREEN R
IVES E
BOYD N
ROSEN B
COLE D
MORGAN K
MOSLEHI R
PONDER B
PETO J
SMITH S
STRATTON M
DICIOCCIO RA
GALLION H
SANTIBANEZKOREF MS
TEARE MD
EVANS DG
STOPPALYONNET D
LALLE P
BONAITI C
ESSIOUX L
GIRODET C
MAUGARDLOUBOUTIN C
NICOLLEAU G
LONGY M
TOULOUSE C
HORSTEIN I
BIRNBAUM D
EISINGER F
KARENGUEVEN F
NOGUCHI T
HARDOUIN A
RIO P
MACHELARDROUMAGNAC M
NOGUES C
COHENHAGUENAUER O
LORTHOLARY A
BAY JO
ARASON A
BARKDARDOTTIR RB
EGILSSON V
BISHOP DT
KELSELL D
MURDAY VA
SOLOMON E
SPURR N
TURNER G
LENOIR G
FEUNTEUN J
LYNCH H
LYNCH J
WATSON P
CONWAY T
BONNARDEL C
SEROVA O
TORCHARD D
LARSSON C
VASEN H
VANLEEUWEN I
CORNELISSE CJ
STEEL M
PORTER D
COHEN BB
CAROTHERS A
CANNONALBRIGHT LA
GOLDGAR D
SKOLNICK M
BECHER H
JOHANNSSON O
WEBER B
COLLINS F
BOEHNKE M
GARBER J
LI F
Citation: Sa. Narod et al., AN EVALUATION OF GENETIC-HETEROGENEITY IN 145 BREAST-CANCER OVARIAN-CANCER FAMILIES, American journal of human genetics, 56(1), 1995, pp. 254-264
Authors:
COHENHAGUENAUER O
Citation: O. Cohenhaguenauer, REGULATION OF GENE-THERAPY IN EUROPE - A CURRENT STATEMENT INCLUDING REFERENCE TO US REGULATION, European journal of cancer, 30A(8), 1994, pp. 1193-1201
Authors:
COHENHAGUENAUER O
Citation: O. Cohenhaguenauer, TECHNOLOGIES AND STRATEGIES OF GENE-THERA PY IN CANCER, Pathologie et biologie, 42(10), 1994, pp. 1065-1067
Authors:
COHENHAGUENAUER O
Citation: O. Cohenhaguenauer, A REVIEW OF CURRENT BASIC APPROACHES TO GENE-THERAPY, Nouvelle revue francaise d'hematologie, 36, 1994, pp. 190000003-190000009
Authors:
RHOERMOJA S
COHENHAGUENAUER O
JOUVE C
HEALY JC
VINDIMIAN M
Citation: S. Rhoermoja et al., DETECTION OF QUANTITATIVE POLYMERASE CHAIN-REACTION PRODUCTS BY HYBRIDIZATION ON MAGNETIC SUPPORT WITH I-125 RADIOLABELED PROBES - QUANTIFICATION OF C-MYC COPY NUMBERS, Analytical biochemistry, 213(1), 1993, pp. 12-18
Risultati:
1-20
|